ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics

Katerina KakosaiouLaboratory of Health Physics, Radiobiology & Cytogenetics, NCSR “Demokritos”, Athens, Greece;

Fotios PanitsasHematology-Lymphoma Department – BMT Unit, Evangelismos Hospital, Athens, Greece;

Aggeliki DarakiLaboratory of Health Physics, Radiobiology & Cytogenetics, NCSR “Demokritos”, Athens, Greece;

Maria PagoniHematology-Lymphoma Department – BMT Unit, Evangelismos Hospital, Athens, Greece;

Paraskevi ApostolouLaboratory of Molecular Diagnostics, NCSR “Demokritos”, Athens, Greece;

Agapi IoannidouLaboratory of Health Physics, Radiobiology & Cytogenetics, NCSR “Demokritos”, Athens, Greece;

Ioanna VlachadamiDepartment of Pathophysiology, 'Laiko' Hospital, University of Athens, Athens, Greece;

Theodoros MarinakisDepartment of Haematology, “Georgios Gennimatas” General Hospital, Athens, Greece;

Chara GiatraHematology-Lymphoma Department – BMT Unit, Evangelismos Hospital, Athens, Greece;

Diamantina VasilatouHematology Unit, University General Hospital “Attikon”, Athens, Greece

Constantina SambaniLaboratory of Health Physics, Radiobiology & Cytogenetics, NCSR “Demokritos”, Athens, Greece;

Vassiliki PappaHematology Unit, University General Hospital “Attikon”, Athens, Greece

Kalliopi N. ManolaLaboratory of Health Physics, Radiobiology & Cytogenetics, NCSR “Demokritos”, Athens, Greece; Correspondence[email protected]

Your download is now in progress and you may close this window